Literature DB >> 11284977

Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens.

M Yamamoto1, Y Doki, H Shiozaki, M Yano, H Miyata, S Tamura, Y Fujiwara, T Yasuda, E Tanaka, T Inoue, M Monden.   

Abstract

The histologic effects of chemoradiation therapy (CRT) for esophageal cancer, which determine the benefit obtained from a salvage operation, are difficult to evaluate preoperatively. We therefore investigated whether or not the morphologic features of esophageal cancer tissue after CRT can be correlated with the histologic features of the tissue. Seventy-six patients with advanced esophageal squamous cell carcinoma underwent CRT followed by esophagectomy. The effects of CRT were evaluated by histologic examination of the residual tumors in the surgical specimen and correlated with clinicopathologic factors, including postoperative prognosis. The histologic effects of CRT were used to classify tumors as grade 1 (CRT poorly effective; 23 cases, 30.3%); grade 2 (CRT moderately effective; 31 cases, 40.8%); or grade 3 (CRT completely effective with no residual tumors; 22 cases, 28.9%). Among the gross findings of the removed esophagus, significant correlation with the CRT effects was observed in the case of wall thickness and ulceration but not in the case of longitudinal tumor length. Tumors with no wall thickening or ulceration were never classified as grade 1, whereas tumors with both wall thickening and ulceration were frequently rated as grade 1 (18/30, 60%). Microscopic examination of grade 2 tumors (23/31, 74.1%) revealed residual tumor cells growing below the mucosal layer, whereas tumor cells were exposed to the esophageal surface in 22 out of 23 patients with grade 1 tumors. The morphologic features after CRT can be used to evaluate its histologic effect, especially in the case of grade 1 tumors. However, the detection and prediction of grade 2 tumors remains difficult because of the presence of small amounts of residual tumor underneath the mucosa.

Entities:  

Mesh:

Year:  2000        PMID: 11284977     DOI: 10.1046/j.1442-2050.2000.00136.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  2 in total

1.  Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Authors:  Robert Díaz; Gaspar Reynes; Alejandro Tormo; Manuel de Juan; Regina Gironés; Angel Segura; Jorge Aparicio; Paula Richart; Helena de la Cueva; José García
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

2.  Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer.

Authors:  Shu Jie Huang; Dan Tian; Si Chao Wang; Rui Jie Zeng; Yue Jiao Dong; Liang Li Hong; Han Sheng Wu; Fang Ping Xu; Dong Kun Zhang; Liang Xie; Hai Yu Zhou; Ji Ming Tang; Xiao Song Ben; Gang Chen; Ri Xin Chen; Yong Tang; Gui Bin Qiao
Journal:  World J Oncol       Date:  2022-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.